![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CARDIOVASCULAR
Instituto de Medicina Sexual, Madrid, Spain (J.A., A.A., I.M., I.S.d.T.); Departamento de Investigación (J.A., P.C., A.F., I.S.d.T.) and Servicio de Urología (A.A.), Hospital Ramón y Cajal, Madrid, Spain; Servicio de Urología, Hospital Gregorio Marañón, Madrid, Spain (I.M.); Servicio de Urología, Hospital Carlos Haya, Málaga, Spain (A.M.-M.); and Serviço de Urologia, Hospital Santo Antonio, Porto, Portugal (J.M.La F.)
We have evaluated the influence of protein kinase C (PKC) activity on penile smooth muscle tone in tissues from diabetic and nondiabetic men with erectile dysfunction. Human corpus cavernosum (HCC) strips were obtained from impotent diabetic and nondiabetic men at the time of penile prosthesis implantation and studied in organ chambers. Contractility responses to a prostanoid precursor, to prostanoids, and to the endothelium-dependent vasodilator acetylcholine were studied. Arachidonic acid (AA; 100 µM) caused cyclooxygenase-dependent relaxation of HCC. This relaxation was impaired in diabetic tissues and normalized by blocking thromboxane (TP) receptors with 20 nM [1S-[1
,2
(Z),3
,4
]]-7-[3-[[2-[(phenylamino)carbonyl]hydrazino]methyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid (SQ29548). Diabetes did not affect prostaglandin (PG)E1-induced relaxation, but it reduced relaxation induced by the PGE1 metabolite PGE0. This effect was related to an interaction of PGE0 with TP receptors. Diabetic tissues had reduced endothelium-dependent relaxation, which was partially improved by SQ29548 and completely normalized by the PKC inhibitor 3-[1-[3-(dimethylaminopropyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride (GF109203X; 1 µM). In HCC from nondiabetic patients, treatment with the PKC activator phorbol-12,13-dibutyrate (0.3 µM) significantly attenuated endothelium-dependent relaxation, an effect prevented by coadministration of GF109203X. Tissues from diabetic patients had enhanced sensitivity to the contractile effects of the TP receptor agonist 9,11-dideoxy-9
,11
-epoxymethano PGF2
(U46619
[GenBank]
) (EC50 = 0.65 ± 0.42 and 6.01 ± 2.28 nM in diabetic and nondiabetic patients, respectively). Inhibition of PKC with 1 µM GF109203X, prevented diabetes-induced hypersensitivity to U46619
[GenBank]
-induced contractions (EC50 = 8.55 ± 3.12 µM). Overactivity of PKC in diabetes is responsible for enhanced contraction and reduced endothelium-dependent relaxation of HCC smooth muscle. Such alterations can result in erectile dysfunction.
Address correspondence to: Dr. Javier Angulo, Servicio de Histologia, Departamento de Investigación, Hospital Ramon y Cajal, Ctra. Colmenar Viejo, km 9.100, 28034 Madrid, Spain. E-mail: jangulo{at}ibercom.com
This article has been cited by other articles:
![]() |
A. C. Bartoo, M. T. Nelson, and G. M. Mawe ATP induces guinea pig gallbladder smooth muscle excitability via the P2Y4 receptor and COX-1 activity Am J Physiol Gastrointest Liver Physiol, June 1, 2008; 294(6): G1362 - G1368. [Abstract] [Full Text] [PDF] |
||||